UCLA Scientists Discover Breakthrough Experimental Therapy to Treat Colon Cancer and Chronic Inflammatory Bowel Disease
University of California, Los Angeles (UCLA), Health SciencesUCLA scientists have discovered a groundbreaking experimental therapy that has the ability to suppress the development of ulcerative colitis (UC), a disease which causes inflammation in the digestive tract and colon cancer. The treatment utilizes a chemical inhibitor able to block an RNA molecule (microRNA-214) involved in the transmission of genetic information.